SureTrader Nadex Advertisement PGUS
Home > Boards > US OTC > Miscellaneous >

Therapeutic Solutions International, Inc. (TSOI)

TSOI RSS Feed
Add TSOI Price Alert      Hide Sticky   Hide Intro
Moderator: centsability4me
Search This Board: 
Last Post: 3/24/2017 12:34:47 PM - Followers: 76 - Board type: Free - Posts Today: 0




 
Share Structure - 46M Float
 
Shares Outstanding 682,751,000 a/o July 13 , 2016
Float 46,312,028 a/o July 13 , 2016
Authorized Shares 995,000,000 a/o July 13 , 2016

Officers and Directors:

 Timothy G. Dixon – President, CEO, & Chairman
Mr. Dixon currently serves as Chief Executive Officer, President, and Chairman of Therapeutic Solutions International, Inc. Mr. Dixon also serves as President and Chairman of OmniBiome, Inc., and President. Mr. Dixon previously served as the President of TMD Courses, Inc. from 2006 to 2012 and; as the President of Splint Decisions Inc. from 2010 to 2011. Mr. Dixon has attended hundreds of hours of continuing medical/dental education throughout the years and has produced many educational DVD’s used by dental professionals worldwide on the subject of parafunctional control, migraine prevention, therapeutic Botox injections, migraine pathophysiology, dental sleep medicine, and other therapeutic protocols. Mr. Dixon also has extensive experience in dealing with corporate compliance matters with the U.S. Food and Drug Administration, (FDA) as well as many international regulatory bodies.
 
Gerry B. Berg – Vice President, CFO, Director
Gerry B. Berg has served as our Vice-President and Chief Financial Officer since April 20, 2011.  Mr. Berg became a director of the Company on August 24, 2012.  Mr. Berg has over 30 years of senior management experience working with private and public companies.  From May 2010 to March 2011, Mr. Berg served as President and Chairman of the Board of Directors of Friendly Auto Dealers, Inc. and also served in a consulting capacity from March 2009 to May 2010.
 
Mr. Berg holds a Bachelors of Science in Accounting from Walsh College where he graduated Cum Laude.  Mr. Berg became a Certified Public Accountant in the State of Michigan in 1979 and in the State of California in 1984.  Mr. Berg does not currently practice as a Certified Public Accountant.
 
Thomas E.Ichim, Ph.D – Director
Dr. Ichim was appointed to the Board of Directors on January 22, 2016.  Dr. Ichim is a seasoned biotechnology entrepreneur with a track record of scientific excellence. He has founded/co-founded several companies including Batu Biologics, Inc., Medvax Pharma Corp, ToleroTech Inc, bioRASI, and OncoMune LLC. To date he has published 99 peer-reviewed articles and is co-editor of the textbooks “RNA Interference: From Bench to Clinical Translation” and “Immuno-Oncology Text Book.”
 
Dr. Ichim is an ad-hoc editor and sits on several editorial boards. Dr Ichim is inventor on over 50 patents and patent applications. Dr. Ichim has extensive experience with stem cell therapy and cellular product development through FDA regulatory pathways. Dr. Ichim spent over 7 years as the President and Chief Scientific Officer of Medistem, developing and commercializing a novel stem cell, the Endometrial Regenerative Cell, through drug discovery, optimization, preclinical testing, IND filing, and up through Phase II clinical trials with the FDA. Dr. Ichim has extensive experience in product development, regulatory filings, and business development.
Dr. Ichim has a BSc in Biology from the University of Waterloo, Waterloo, Ontario, Canada, a MSc in Microbiology and Immunology a University of Western Ontario, London, Ontario, Canada and a Ph.D in Immunology from the University of Sciences Arts and Technology, Olveston Monserrat.
 
Hong Ma, MD, Ph.D., M.B.A. – Chief Scientific Officer
Dr. Ma has an extensive history in academic and translational research. Subsequent to completing her medical degree, she performed basic research in the area of molecular biology of endothelial-associated pathways in her doctorate and postdoctoral studies. She has been critical in establishing numerous ventures and collaborations in the area of biosciences. Dr. Ma has over 20 peer-reviewed publications and has worked with prestigious institutions in the USA, China, and Japan. She received her M.D. from Dalian Medical University, her Ph.D. in Cardiovascular Pharmacology at Asahikawa Medical College, and has also earned her MBA at the Rady School of Management at the University of California San Diego.
 

 

Therapeutic Solutions International, Inc. Subsidiaries and Divisions

As of July 20, 2016 TSI owns approximately 73.75% of the outstanding shares of OmniBiome, Inc. See www.omnibiomeinc.com
 





Contact :

CEO email address:

timdixon@therapeuticsolutionsint.com  

Address:
Therapeutic Solutions International, Inc.
4093 Oceanside Blvd Suite B
Oceanside CA 92056

Email: ir@tsoimail.com

Websites:
Corporate: www.therapeuticsolutionsint.com
E-Commerce: www.youcanordernow.com 
ProJuvenol: www.projuvenol.com

Disclaimer : All of the information presented in the IBOX , Stickies , or postings on this board is based on individual opinions , and is not to be considered as a recommendation to buy , sell , or hold this stock .
 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TSOI
Current Price
Volume:
Bid Ask Day's Range
SureTrader
TSOI News: Quarterly Report (10-q) 03/09/2017 05:07:55 PM
TSOI News: Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol 02/06/2017 08:48:27 AM
TSOI News: Amended Annual Report (10-k/a) 01/25/2017 04:03:16 PM
TSOI News: Current Report Filing (8-k) 11/10/2016 02:49:03 PM
TSOI News: Annual Report (10-k) 10/31/2016 05:02:07 PM
PostSubject
#5670   .0074 X .0088 centsability4me 03/24/17 12:34:47 PM
#5669   and news centsability4me 03/23/17 08:21:05 AM
#5668   .071 X .092 corvatsch 03/22/17 05:38:06 PM
#5667   .071 X .092 centsability4me 03/22/17 01:35:27 PM
#5666   0.0093 X 0.0125 centsability4me 03/14/17 11:31:02 AM
#5665   0,01 $$$$$... corvatsch 03/13/17 11:20:10 AM
#5664   Does anyone know what the restriction period is cantbelieveit 03/10/17 07:10:07 AM
#5663   TSOI 10-Q Filed... stervc 03/10/17 01:37:59 AM
#5662   OK !!!! corvatsch 02/16/17 05:37:30 PM
#5661   Cor, It needs more volume to narrow the spread centsability4me 02/16/17 05:27:21 PM
#5660   0,0062 ???? corvatsch 02/16/17 04:38:59 PM
#5659   good to see some volume centsability4me 02/16/17 10:33:15 AM
#5658   Someone bought a lot of 011's shurtha2000 02/16/17 10:12:04 AM
#5657   Link to new Pterostilbene study info : centsability4me 02/14/17 07:15:34 AM
#5656   $TSOI New Facebook Post on Pterostilbene inhibiting tumor cantbelieveit 02/08/17 03:10:03 PM
#5655   Only a 45M Float - can you imagine shurtha2000 02/08/17 12:09:44 PM
#5654   ***TSOI NEWS 2/6/17*** centsability4me 02/06/17 08:38:52 AM
#5653   Wow, this thing is just going up and Abbas14 02/04/17 10:43:39 AM
#5652   Another TSI Patent published corvatsch 02/03/17 07:47:17 AM
#5651   Another TSI Patent published centsability4me 02/03/17 07:23:14 AM
#5649   Bio Pharma startups centsability4me 02/01/17 08:03:40 AM
#5648   From the recent 10K filing, centsability4me 01/27/17 09:21:32 AM
#5647   we will know more centsability4me 01/24/17 01:45:26 PM
#5646   cor , nevjon 01/20/17 01:09:48 PM
#5645   0,0016- 0,0022..... corvatsch 01/20/17 11:47:17 AM
#5644   nev, i think it's sleeping - ;>) centsability4me 01/18/17 04:36:10 PM
#5643   cents , nevjon 01/17/17 08:27:04 AM
#5642   I'll bet if you put in a buy cantbelieveit 01/05/17 05:49:40 PM
#5641   does not exchange ? problems corvatsch 01/05/17 04:31:35 PM
#5640   Nev, TSOI has those two Projuvenol / pterostilbene patents centsability4me 12/12/16 08:22:15 AM
#5639   cents, thxs for the recap, do you think tsoi nevjon 12/11/16 05:21:51 PM
#5638   TSOI Recap centsability4me 11/28/16 08:38:34 AM
#5637   nev , corvatsch 11/23/16 04:08:53 PM
#5636   Cents , nevjon 11/23/16 12:18:02 PM
#5635   nev , centsability4me 11/23/16 09:55:30 AM
#5634   centsability4me wondering what is going with this company nevjon 11/19/16 10:47:40 PM
#5633   TSI Projuvenol Patent has published centsability4me 11/15/16 07:15:23 AM
#5632   R/S coming per NVSOS Filing (hit today) DaReal 11/07/16 04:47:58 PM
#5631   He also states they have started to assert cantbelieveit 11/01/16 06:56:55 AM
#5630   Looks like a lot of shares issued..... And Brooksda 10/31/16 11:21:30 PM
#5629   10K out centsability4me 10/31/16 09:31:00 PM
#5628   The Curcumin Liposomal centsability4me 10/29/16 08:08:46 AM
#5627   Certainly not a pump-n-dump, but a real company cantbelieveit 10/26/16 07:48:32 PM
#5626   cantbelieveit looks like insiders bought what do you know nevjon 10/26/16 07:43:31 PM
#5625   No. Their website has been under construction cantbelieveit 10/26/16 06:41:34 PM
#5624   cantbelieveit have you herd anything about capo nevjon 10/26/16 06:36:35 PM
#5623   Interesting article with mention of one of our cantbelieveit 10/26/16 06:28:19 PM
#5622   There should be another filing coming out soon cantbelieveit 10/14/16 07:13:56 AM
#5621   a good hold for us here. News will LoveItInBishop 10/10/16 01:35:03 PM
#5620   no trades for a week !!! corvatsch 10/04/16 02:38:11 PM
PostSubject